Chemotherapy; New data illuminates research in chemotherapy
Chemotherapy; New data illuminates research in chemotherapy
About this item
Full title
Chemotherapy; New data illuminates research in chemotherapy
Publisher
Atlanta: NewsRx
Journal title
Science Letter, 2006, p.322
Language
English
Formats
Publication information
Publisher
Atlanta: NewsRx
Subjects
More information
Scope and Contents
Contents
"Patients (n=147) with stage IV NSCLC pretreated with a taxane/ gemcitabine regimen were randomly assigned to receive either irinotecan (110 mg/m[sup]2, day 1 and 100 mg/m[sup]2, day 8) and cisplatin (80 mg/m[sup]2, day 8) (IC; n=74) or CDDP (80 mg/m[sup]2, day 1) (C; n=73) every 3 weeks," explained V. Georgoulias and colleagues, University of Gene...
Alternative Titles
Full title
Chemotherapy; New data illuminates research in chemotherapy
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_wirefeeds_209105772
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_209105772
Other Identifiers
ISSN
1538-9111
E-ISSN
1538-9162
How to access this item
Log in as a Library member
